An advanced network pharmacology study to explore the novel molecular mechanism of Compound Kushen Injection for treating hepatocellular carcinoma by bioinformatics and experimental verification

BACKGROUND: Compound Kushen Injection (CKI) is a Chinese patent drug that exerts curative effects in the clinical treatment of hepatocellular carcinoma (HCC). This study aimed to explore the targets and potential pharmacological mechanisms of CKI in the treatment of HCC. METHODS: In this study, netw...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Shan, Meng, Ziqi, Tan, Yingying, Wu, Chao, Huang, Zhihong, Huang, Jiaqi, Fu, Changgeng, Stalin, Antony, Guo, Siyu, Liu, Xinkui, You, Leiming, Li, Xiaojiaoyang, Zhang, Jingyuan, Zhou, Wei, Zhang, Xiaomeng, Wang, Miaomiao, Wu, Jiarui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892752/
https://www.ncbi.nlm.nih.gov/pubmed/35236335
http://dx.doi.org/10.1186/s12906-022-03530-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892752/
https://www.ncbi.nlm.nih.gov/pubmed/35236335
http://dx.doi.org/10.1186/s12906-022-03530-3

Ejemplares similares